€17.40
0.51% today
Xetra, Aug 21, 05:35 pm CET
ISIN
DE0005659700
Symbol
EUZ
Index

Eckert & Ziegler Strahlen- und Medizintechnik Stock price

€17.40
-4.68 21.21% 1M
-2.78 13.79% 6M
+2.57 17.30% YTD
+4.16 31.41% 1Y
+4.83 38.47% 3Y
+5.59 47.36% 5Y
+15.84 1,014.60% 10Y
+16.37 1,586.86% 20Y
Xetra, Closing price Thu, Aug 21 2025
-0.09 0.51%
ISIN
DE0005659700
Symbol
EUZ
Index

Key metrics

Basic
Market capitalization
€1.1b
Enterprise Value
€1.1b
Net debt
positive
Cash
€112.3m
Shares outstanding
62.6m
Valuation (TTM | estimate)
P/E
30.2 | 7.5
P/S
3.8 | 3.4
EV/Sales
3.6 | 3.2
EV/FCF
18.8
P/B
5.0
Dividends
DPS
€0.17
Yield 1Y | 5Y
1.0% | 0.8%
Growth 1Y | 5Y
1,004.0% | 5.4%
Payout 1Y | 3Y
10.5% | 7.8%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€299.3m | €329.9m
EBITDA
€85.1m | €98.2m
EBIT
€64.9m | €81.9m
Net Income
€36.6m | €145.4m
Free Cash Flow
€56.8m
Growth (TTM | estimate)
Revenue
9.4% | 11.5%
EBITDA
18.6% | 39.8%
EBIT
12.1% | 26.7%
Net Income
9.6% | 336.8%
Free Cash Flow
338.7%
Margin (TTM | estimate)
Gross
48.0%
EBITDA
28.4% | 29.8%
EBIT
21.7%
Net
12.2% | 44.1%
Free Cash Flow
19.0%
Financial Health
Equity Ratio
50.5%
Return on Equity
14.9%
ROCE
17.9%
ROIC
17.2%
Debt/Equity
0.2
More
EPS
€0.6
FCF per Share
€0.9
Short interest
-
Employees
1k
Rev per Employee
€270.0k
Show more

Is Eckert & Ziegler Strahlen- und Medizintechnik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,014 stocks worldwide.

Eckert & Ziegler Strahlen- und Medizintechnik Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast:

4x Buy
67%
2x Hold
33%

Analyst Opinions

6 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast:

Buy
67%
Hold
33%

Financial data from Eckert & Ziegler Strahlen- und Medizintechnik

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
299 299
9% 9%
100%
- Direct Costs 156 156
10% 10%
52%
144 144
9% 9%
48%
- Selling and Administrative Expenses 73 73
7% 7%
24%
- Research and Development Expense - -
-
-
85 85
19% 19%
28%
- Depreciation and Amortization 20 20
46% 46%
7%
EBIT (Operating Income) EBIT 65 65
12% 12%
22%
Net Profit 37 37
10% 10%
12%

In millions EUR.

Don't miss a Thing! We will send you all news about Eckert & Ziegler Strahlen- und Medizintechnik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eckert & Ziegler Strahlen- und Medizintechnik Stock News

AD HOC NEWS
14 days ago
Der Strahlen- und Medizintechnikkonzern Eckert & Ziegler DE0005659700 hat die Probleme durch eine Cyberattacke im Februar und den zeitlich einhergehenden Auslieferungsstopp für Gallium-Generatoren weitgehend aufgeholt.
AD HOC NEWS
14 days ago
Eckert & Ziegler DE0005659700 hat die Probleme durch eine Cyberattacke im Februar und den zeitlich einhergehenden Auslieferungsstopp für Gallium-Generatoren weitgehend aufgeholt.
More Eckert & Ziegler Strahlen- und Medizintechnik News

Company Profile

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, and Radiopharma. The Radiation Therapy segment includes the production and distribution of medical products for the treatment of cancer using brachytherapy. The Isotope Products segment manufactures and distributes sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment is specialized in the field of molecular imaging and nuclear medicine, supplying different radiopharmaceuticals, radiochemicals and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Head office Germany
CEO Harald Hasselmann
Employees 1,085
Founded 1997
Website www.ezag.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today